These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 15670896)
1. RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women. Kelemen L; Spurdle AB; Purdie DM; Gertig D; Chenevix-Trench G Cancer Lett; 2005 Feb; 218(2):191-7. PubMed ID: 15670896 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759 [TBL] [Abstract][Full Text] [Related]
3. PGR +331 A/G and increased risk of epithelial ovarian cancer. Risch HA; Bale AE; Beck PA; Zheng W Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1738-41. PubMed ID: 16985038 [TBL] [Abstract][Full Text] [Related]
4. The C19007T polymorphism of ERCC1 and its correlation with the risk of epithelial ovarian and endometrial cancer in Korean women. A case control study. Jo H; Kang S; Kim SI; Kim JW; Park NH; Song YS; Park SY; Kang SB; Lee HP Gynecol Obstet Invest; 2007; 64(2):84-8. PubMed ID: 17314486 [TBL] [Abstract][Full Text] [Related]
5. Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Webb PM; Hopper JL; Newman B; Chen X; Kelemen L; Giles GG; Southey MC; Chenevix-Trench G; Spurdle AB Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):319-23. PubMed ID: 15734952 [TBL] [Abstract][Full Text] [Related]
6. E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese. Li Y; Liang J; Kang S; Dong Z; Wang N; Xing H; Zhou R; Li X; Zhao X Gynecol Oncol; 2008 Feb; 108(2):409-14. PubMed ID: 18035404 [TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. Auranen A; Song H; Waterfall C; Dicioccio RA; Kuschel B; Kjaer SK; Hogdall E; Hogdall C; Stratton J; Whittemore AS; Easton DF; Ponder BA; Novik KL; Dunning AM; Gayther S; Pharoah PD Int J Cancer; 2005 Nov; 117(4):611-8. PubMed ID: 15924337 [TBL] [Abstract][Full Text] [Related]
8. Estrogen bioactivation, genetic polymorphisms, and ovarian cancer. Sellers TA; Schildkraut JM; Pankratz VS; Vierkant RA; Fredericksen ZS; Olson JE; Cunningham J; Taylor W; Liebow M; McPherson C; Hartmann LC; Pal T; Adjei AA Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2536-43. PubMed ID: 16284375 [TBL] [Abstract][Full Text] [Related]
10. Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer. Leite DB; Junqueira MG; de Carvalho CV; Massad-Costa AM; Gonçalves WJ; Nicolau SM; Lopes LA; Baracat EC; da Silva ID Steroids; 2008 Jul; 73(6):676-80. PubMed ID: 18384825 [TBL] [Abstract][Full Text] [Related]
11. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma]. Liang J; Li Y; Wang N Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242 [TBL] [Abstract][Full Text] [Related]
13. The N314D polymorphism of galactose-1-phosphate uridyl transferase does not modify the risk of ovarian cancer. Fung WL; Risch H; McLaughlin J; Rosen B; Cole D; Vesprini D; Narod SA Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):678-80. PubMed ID: 12869412 [TBL] [Abstract][Full Text] [Related]
14. ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy. Smith S; Su D; Rigault de la Longrais IA; Schwartz P; Puopolo M; Rutherford TJ; Mor G; Yu H; Katsaros D J Clin Oncol; 2007 Nov; 25(33):5172-9. PubMed ID: 18024864 [TBL] [Abstract][Full Text] [Related]
15. The MnSOD Val9Ala polymorphism, dietary antioxidant intake, risk and survival in ovarian cancer (Australia). Johnatty SE; Nagle CM; Spurdle AB; Chen X; ; Webb PM; Chenevix-Trench G Gynecol Oncol; 2007 Dec; 107(3):388-91. PubMed ID: 17936883 [TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Lu L; Katsaros D; de la Longrais IA; Sochirca O; Yu H Cancer Res; 2007 Nov; 67(21):10117-22. PubMed ID: 17974952 [TBL] [Abstract][Full Text] [Related]
18. Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population. Franeková M; Zúbor P; Stanclová A; Dussan CA; Bohusová T; Galo S; Dobrota D; Kajo K; Péc M; Racay P Neoplasma; 2007; 54(2):155-61. PubMed ID: 17319790 [TBL] [Abstract][Full Text] [Related]
19. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers. Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979 [TBL] [Abstract][Full Text] [Related]
20. Body size and risk of epithelial ovarian cancer (United States). Rossing MA; Tang MT; Flagg EW; Weiss LK; Wicklund KG; Weiss NS Cancer Causes Control; 2006 Jun; 17(5):713-20. PubMed ID: 16633919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]